dm+d

60881009

Articles

Diamorphine hydrochloride: informing intrathecal risk assessment

11 August 2022Diamorphine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Supply and/or administration of Controlled Drugs under a PGD

16 November 2021This article summarises the legal position on the supply and/or administration of controlled drugs under PGDs.
Search Articles

Medicine Compliance Aid Stability

genericAurum Pharmaceuticals Ltd

Aurum Pharmaceuticals Ltd
generic
Tablets 10mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from light.
3 April 2022

Lactation Safety Information

For pain

For pain
Morphine
No published evidence of safety
Risk of serious adverse effects in breastfed infants
Infant monitoring advised, especially in young infants (see summary)
30 July 2020